Left Menu
Development News Edition

UK to host 'human challenge' trials for COVID-19 vaccines -FT

Britain is planning to host clinical trials where volunteers are deliberately infected with the new coronavirus to test the effectiveness of vaccine candidates, the Financial Times reported on Wednesday, citing people involved in the project. So-called "challenge trials" are expected to begin in January at a quarantine facility in London, the report https://on.ft.com/2G5o0jP said, adding that about 2,000 participants had signed up through a U.S.-based advocacy group, 1Day Sooner.

Reuters | London | Updated: 24-09-2020 14:18 IST | Created: 24-09-2020 14:07 IST
UK to host 'human challenge' trials for COVID-19 vaccines -FT
Representative image Image Credit: ANI

Britain is planning to host clinical trials where volunteers are deliberately infected with the new coronavirus to test the effectiveness of vaccine candidates, the Financial Times reported on Wednesday, citing people involved in the project.

So-called "challenge trials" are expected to begin in January at a quarantine facility in London, the report https://on.ft.com/2G5o0jP said, adding that about 2,000 participants had signed up through a U.S.-based advocacy group, 1Day Sooner. (https://on.ft.com/2G5o0jP) Britain said it was working with partners on the potential for human challenge trials without commenting on a specific plan.

"We are working with partners to understand how we might collaborate on the potential development of a COVID-19 vaccine through human challenge studies," a government spokeswoman said. "These discussions are part of our work to research ways of treating, limiting and hopefully preventing the virus so we can end the pandemic sooner."

The FT reported that the studies will be government funded, although 1Day Sooner said it would also launch a petition for public funding of a biocontainment facility big enough to quarantine 100 to 200 participants. Open Orphan, a pharmaceutical services company cited in the FT report, confirmed in a statement early on Thursday that it is in "advanced negotiation with the UK Government and other partners for a coronavirus challenge study in the UK".

"There can be no certainty that these discussions will lead to a new contract," it added. Imperial College London, cited by the FT as the academic lead on the trials, did not confirm the report.

"Imperial continues to engage in a wide range of exploratory discussions relating to COVID-19 research, with a variety of partners," a spokeswoman said, asked about the possibility of challenge trials. Any trials conducted in the United Kingdom would have to be approved by the Medicines and Healthcare products Regulatory Agency (MHRA), the healthcare regulator which looks into safety and protocol.

The MHRA did not respond to Reuters' requests for comment, but 1Day Sooner, which lobbies for challenge trials to accelerate vaccine development, welcomed the report. "1Day Sooner congratulates the British government on their plans to conduct challenge trials to test vaccines," it said in a statement, confirming it would petition the government to house the trial participants.

The industry has seen discussions in recent months about potentially having to inject healthy volunteers with the novel coronavirus if drugmakers struggled to find enough patients for final trials. The FT report did not name the vaccines that would be assessed in the project. British drugmaker AstraZeneca, and French firm Sanofi both told Reuters that their vaccine candidates were not involved in the programme.


TRENDING

OPINION / BLOG / INTERVIEW

Uganda COVID-19 response: Was off to a good start but reopening dwindled prospects

Uganda has shown success in using health information to enhance efficiency of disease surveillance, reporting and monitoring. The success, however, has critical challenges confronting it as the country resumes normal activities....

New farm bills in India: Focusing on farms or farmers?

... ...

Kenya’s COVID-19 response: Chaos amid lack of information

Confusing numbers and scanty information on how effective curfews and lockdowns have been in breaking transmission have amplified coordination and planning challenges in Kenyas response to COVID-19. Without accurate data, it is impossible t...

Farkhad Akhmedov: Calculating the price of impunity from the law

In insistences such as the battle over the Luna, Akhmedov has resorted to extreme legal machinations to subvert the High Courts decision and keep his assets from being seized. ...

Videos

Latest News

Pompeo visits St Anthony's Church in Colombo; pays tribute to victims of Easter attacks

US Secretary of State Mike Pompeo on Wednesday visited the St Anthonys Church in north Colombo, one of the three churches devastated by the horrific Easter Sunday attacks in 2019, and paid tributes to the victims of the deadly terror strike...

Indian parliamentary panel slams Twitter in China map dispute

The head of an Indian parliamentary panel accused Twitter of disrespecting New Delhis sovereignty on Wednesday, after mapping data showed Indian-ruled territory as part of China in what the social network said was a quickly resolved mistake...

Gold smuggling case: Suspended IAS officer taken into ED custody; Oppn demand CM's resignation

Suspended IAS officer M Sivasankar, facing probe in the Kerala gold smuggling case, was taken into custody by the ED from a hospital in Thiruvananthapuram on Wednesday, minutes after a court rejected his anticipatory bail pleas in the matte...

EU must step up response to COVID-19, Commission warns as infections spike

The European Commission proposed on Wednesday a series of new measures to fight the COVID-19 pandemic in the European Union, saying the new spike in infections on the continent was alarming. As Europe again becomes the worlds epicentre of t...

Give Feedback